Investor Relations

Company Overview

Assembly Biosciences, Inc. (Nasdaq: ASMB) is a public biotechnology company advancing a new class of oral biologic drugs for addressing the gut microbiome and novel approaches to discovering drugs for the treatment of hepatitis B virus (HBV) infection.

Stock Quote

NASDAQ: ASMB
23.84
- 0.15 (-0.61%)
1:10 PM ET on Apr 26, 2017
Delayed at least 20 minutes.

Stock Chart

Press Releases

Events & Presentations

Investor Contact

investors@assemblybio.com